Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristyna Vrbova

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Nanomaterials (Basel, Switzerland)|July 5, 2019
Toxicity of TiO<sub>2</sub>, ZnO, and SiO<sub>2</sub> Nanoparticles in Human Lung Cells: Safe-by-Design Development of Construction MaterialsMonika Remzova, Radek Zouzelka, Tana Brzicova, et al.
Scientific Reports|January 6, 2026
Monitoring and assessment of potentially hazardous particles in high-risk workplaces in the production of Ni-Cd batteriesMichaela Tokarčíková, Šárka Bernatíková, Pavel Rössner, et al.
Patient Preference and Adherence|March 29, 2016
Are self-stigma, quality of life, and clinical data interrelated in schizophrenia spectrum patients? A cross-sectional outpatient studyMichaela Holubova, Jan Prasko, Klara Latalova, et al.
Nanomaterials (Basel, Switzerland)|August 27, 2021
Testing Strategies of the In Vitro Micronucleus Assay for the Genotoxicity Assessment of Nanomaterials in BEAS-2B CellsTereza Cervena, Andrea Rossnerova, Tana Zavodna, et al.
Neuropsychiatric Disease and Treatment|June 19, 2018
Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients - a cross-sectional studyKristyna Vrbova, Jan Prasko, Marie Ociskova, et al.
Neuropsychiatric Disease and Treatment|June 2, 2015
Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disordersMarie Ociskova, Jan Prasko, Dana Kamaradova, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|June 12, 2020
Genotoxicant exposure, activation of the aryl hydrocarbon receptor, and lipid peroxidation in cultured human alveolar type II A549 cellsPavel Rossner, Helena Libalova, Kristyna Vrbova, et al.
Neuropsychiatric Disease and Treatment|March 7, 2017
Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional studyKristyna Vrbova, Jan Prasko, Marie Ociskova, et al.
Neuropsychiatric Disease and Treatment|December 7, 2016
Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders - a cross-sectional studyMichaela Holubova, Jan Prasko, Stanislav Matousek, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 2, 2011
Bipolar affective disorder and dissociation--comparison with healthy controlsKlara Latalova, Jan Prasko, Petr Pastucha, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Nanomaterials (Basel, Switzerland)|July 5, 2019
Toxicity of TiO<sub>2</sub>, ZnO, and SiO<sub>2</sub> Nanoparticles in Human Lung Cells: Safe-by-Design Development of Construction MaterialsMonika Remzova, Radek Zouzelka, Tana Brzicova, et al.
Scientific Reports|January 6, 2026
Monitoring and assessment of potentially hazardous particles in high-risk workplaces in the production of Ni-Cd batteriesMichaela Tokarčíková, Šárka Bernatíková, Pavel Rössner, et al.
Patient Preference and Adherence|March 29, 2016
Are self-stigma, quality of life, and clinical data interrelated in schizophrenia spectrum patients? A cross-sectional outpatient studyMichaela Holubova, Jan Prasko, Klara Latalova, et al.
Nanomaterials (Basel, Switzerland)|August 27, 2021
Testing Strategies of the In Vitro Micronucleus Assay for the Genotoxicity Assessment of Nanomaterials in BEAS-2B CellsTereza Cervena, Andrea Rossnerova, Tana Zavodna, et al.
Neuropsychiatric Disease and Treatment|June 19, 2018
Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients - a cross-sectional studyKristyna Vrbova, Jan Prasko, Marie Ociskova, et al.
Neuropsychiatric Disease and Treatment|June 2, 2015
Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disordersMarie Ociskova, Jan Prasko, Dana Kamaradova, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|June 12, 2020
Genotoxicant exposure, activation of the aryl hydrocarbon receptor, and lipid peroxidation in cultured human alveolar type II A549 cellsPavel Rossner, Helena Libalova, Kristyna Vrbova, et al.
Neuropsychiatric Disease and Treatment|March 7, 2017
Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional studyKristyna Vrbova, Jan Prasko, Marie Ociskova, et al.
Neuropsychiatric Disease and Treatment|December 7, 2016
Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders - a cross-sectional studyMichaela Holubova, Jan Prasko, Stanislav Matousek, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 2, 2011
Bipolar affective disorder and dissociation--comparison with healthy controlsKlara Latalova, Jan Prasko, Petr Pastucha, et al.
Pageof 5